Email this article The value of bone mineral density assessment by dual-energy x-ray absorptiometry for prediction of cardiovascular mortality in patients treated with hemodialysis
- Authors: Mazurenko S.O.1,2, Nakatis Y.A.1,2, Enkin A.A.3, Staroselsky K.G.4, Vasiliev A.N.5, Mazurenko O.G.2, Soin P.V.4, Ermolaeva L.G.4, Ivanov I.G.1
-
Affiliations:
- Saint Petersburg State University
- Sokolov Clinical Hospital №122
- Leningrad Regional Clinical Hospital
- City Hospital №26
- Pavlov First Saint Petersburg State Medical University
- Issue: Vol 92, No 6 (2020)
- Pages: 33-36
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/34980
- DOI: https://doi.org/10.26442/00403660.2020.06.000277
- ID: 34980
Cite item
Full Text
Abstract
Aim. Determine whether bone mineral density (BMD) assessed by dual-energy x-ray absorptiometry can be used as predictor of increased risk of death in hemodialysis patients.
Materials and methods. A prospective study was performed of 516 patients with chronic kidney disease treated with hemodialysis (men – 265, women – 251, mean age 44.8±11.4 years) who were observed for 5.7±3.2 years.
Before inclusion in the study, in all patients was analyzed bone mineral density using dual-energy X-ray absorptiometry in three standard departments: lumbar vertebrae, proximal femur and distal forearm. The probability analysis of the outcome was carried out using the Kaplan–Meier method and Cox.
Results. During follow-up period 111 (21.5%) patients died, 50.5% from cardiovascular events. Survival analysis by Kaplan–Meier method allowed to prove the increased risk of death from cardiovascular pathology in hemodailysis patients with low bone mineral density of all evaluated areas. Step-by-step multivariate Cox regression analysis showed that the T score of the femur, showing the difference of BMD of the patient with normal value of BMD for young adult, had the greatest prognostic significance.
Conclusion. Reduced bone mineral density in patients receiving hemodialysis is associated with an increased risk of death from cardiovascular disease. Dual energy x-ray absorptiometry can be used for assessment of this risk.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sergey O. Mazurenko
Saint Petersburg State University; Sokolov Clinical Hospital №122
Author for correspondence.
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0002-1915-2237
д.м.н., проф., зав. каф. пропедевтики внутренних болезней; рук. Центра остеопороза и метаболических заболеваний скелета
Russian Federation, Saint PetersburgYakov A. Nakatis
Saint Petersburg State University; Sokolov Clinical Hospital №122
Email: dr_mazurenko@mail.ru
д.м.н., проф.; глав. врач
Aleksander A. Enkin
Leningrad Regional Clinical Hospital
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0003-2305-9673
зав. отд-нием диализа
Russian Federation, Saint PetersburgKonstantin G. Staroselsky
City Hospital №26
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0002-3956-1628
зав. отд-нием диализа
Russian Federation, Saint PetersburgAleksander N. Vasiliev
Pavlov First Saint Petersburg State Medical University
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0002-0529-3880
зав. отд-нием хронического гемодиализа
Russian Federation, Saint PetersburgOksana G. Mazurenko
Sokolov Clinical Hospital №122
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0003-1922-5309
к.м.н., врач-рентгенолог Центра остеопороза и метаболических заболеваний скелета
Russian Federation, Saint PetersburgPetr V. Soin
City Hospital №26
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0003-4162-6686
врач отд-ния диализа
Russian Federation, Saint PetersburgLarisa G. Ermolaeva
City Hospital №26
Email: dr_mazurenko@mail.ru
ORCID iD: 0000-0002-5040-6768
к.м.н., доц. каф. пропедевтики внутренних болезней
Russian Federation, Saint PetersburgIgor G. Ivanov
Saint Petersburg State University
Email: dr_mazurenko@mail.ru
Russian Federation, Saint Petersburg
References
- Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet. 2008;371(9631):2173-82. doi: 10.1016/S0140-6736(08)60952-6
- Gibertoni D, Mandreoli M, Rucci P, et al. Excess mortality attributable to chronic kidney disease. Results from the PIRP project. J Nephrol. 2016;29(5):663-71. doi: 10.1007/s40620-015-0239-4
- Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kidney Dis. 2001;38(6):1398-407. doi: 10.1053/ajkd.2001.29275
- Rivara MB, Ravel V, Kalantar-Zadeh K, et al. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. J Am Soc Nephrol. 2015;26(7):1671-81. doi: 10.1681/ASN.2014050472
- Krutko DM, Mazurenko SO, Staroselsky KG, et al. Control of Hemodialysis Therapy Based on the Bioelectrical Impedance Analysis. Biomed Eng. 2016;50:189. doi: 10.1007/s10527-016-9616-0
- Sun J, Axelsson J, Machowska A, et al. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol. 2016;11(7):1163-72. doi: 10.2215/CJN.10441015
- Qu X, Huang X, Jin F, et al. Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;166(2):385-93. doi: 10.1016/j.ijcard.2011.10.114
- Farhat GN, Newman AB, Sutton-Tyrrell K, et al.; Health ABC Study. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int. 2007;18(7):999-1008. doi: 10.1007/s00198-007-0338-8
- Ambrus C, Marton A, Nemeth ZK, Mucsi I. Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol. 2010;42:723-39. doi: 10.1007/s11255-009-9666-2
- Mazurenko SO, Mazurenko OG, Enkin AA, et al. Use of dual energy x-ray absorptiometry for assessment of fracture risk in dialysis patients. Biomed Eng. 2017;51:20. doi: 10.1007/s10527-017-9676-9
- DeLoach SS, Townsend RR. Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies. Clin J Am Soc Nephrol. 2008;3(1):184-92. doi: 10.2215/CJN.03340807
- Malluche HH, Blomquist G, Monier-Faugere MC, et al. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients in dialysis. J Am Soc Nephrol. 2015;26(10):2534-44. doi: 10.1681/ASN.2014070686
Supplementary files
